MedTrace Logo

V-Lap System For Wirelessly Measuring And Monitoring Left Atrial Pressure (LAP) In Patients With Advance Chronic Heart Failure

NCT05448833 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-05-30

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and performance of the V-LAP System in subjects with New York Heart Association (NYHA) functional class II and III HF, irrespective of left ventricular ejection fraction.

Conditions

Interventions

DEVICE

V-LAP™ SYSTEM

Delivery of the V-LAP™ implant by right heart catheterization. A catheter-based approach in a trans-septal puncture procedure, deploying it in the inter-atrial septum.

Sponsors & Collaborators

  • Vectorious Medical Technologies Ltd.

    lead INDUSTRY

Principal Investigators

  • Antonio Bayés-Genís, MD PhD · Universitari Germans Trias i Pujol in Badalona

  • David Meerkin, MD · Shaare Zedek Medical Center Jerusalem, Israel

  • Ran Kornowski, MD PhD · Rabin Belinson, Medical Center - Israel

  • Filippo Crea, MD PhD · Universitario Agostino Gemelli

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
88 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-31
Primary Completion
2025-12-31
Completion
2027-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05448833 on ClinicalTrials.gov